Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 27, 2025 09:00 ET | Source: Gala Games

Gala Introduces Solana Bridge for GalaChain, Expanding Cross-Chain Utility

Gala introduces Solana Bridge for GalaChain, expanding cross-chain utility.
December 06, 2023 08:30 ET | Source: Fortress Biotech, Inc.

Cyprium Therapeutics, a Fortress Biotech Subsidiary Company, Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease, to Sentynl Therapeutics, a Wholly-owned Subsidiary of Zydus Lifesciences Ltd.

Cyprium received $4.5 million payment upon closing and remains eligible to receive royalties and up to $129 million in aggregate development and sales milestones Cyprium will retain 100% ownership...